Mass General Brigham Medical Group Northern Massachusetts INC
Mass General Brigham Medical Group Northern Massachusetts INC was paid $30.22M by Medicaid between Jan 2018 and Dec 2024, across 160 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 23% of everything it billed.
SALEM, MA 01970
Next to other Internal Medicine Physician providers in Massachusetts
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 102,663 | $3.97M | |
| 2019 | 103,805 | $4.17M | |
| 2020 | 91,378 | $3.70M | |
| 2021 | 133,461 | $5.03M | |
| 2022 | 129,770 | $5.28M | |
| 2023 | 129,677 | $4.55M | |
| 2024incomplete | 106,345 | $3.52M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 23% | 165,200 | 160,040 | $7.08M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 20% | 75,552 | 74,446 | $6.09M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 13% | 51,382 | 50,729 | $3.92M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.1% | 49,612 | 47,751 | $1.86M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 5.5% | 39,121 | 38,831 | $1.66M |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 4.3% | 38,416 | 19,241 | $1.31M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 3.5% | 45,985 | 21,345 | $1.07M |
| 99223 | Prolong inpt eval add15 m | 2.5% | 10,552 | 10,385 | $765K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.2% | 8,174 | 8,146 | $668K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.2% | 17,119 | 16,451 | $663K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 2.0% | 7,420 | 4,683 | $618K |
| 99239 | Hospital discharge day management, more than 30 minutes | 1.9% | 15,214 | 14,918 | $571K |
148 more codes
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.9% | 11,170 | $571K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1.5% | 108,940 | $448K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.4% | 11,090 | $435K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 3,096 | $160K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 3,438 | $158K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 2,337 | $140K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 2,184 | $114K |
| 99205 | Prolong outpt/office vis | <1% | 1,061 | $111K |
| 99254 | <1% | 558 | $105K | |
| 99220 | <1% | 1,522 | $98K | |
| 0001A | <1% | 2,647 | $96K | |
| 0002A | <1% | 2,453 | $92K | |
| 93000 | <1% | 13,887 | $89K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 2,954 | $88K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 676 | $81K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 4,612 | $77K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 1,309 | $72K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 10,503 | $67K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,119 | $65K |
| 90686 | <1% | 4,223 | $51K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 7,350 | $44K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 4,693 | $40K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 5,028 | $40K |
| 99310 | Prolong nursin fac eval 15m | <1% | 3,643 | $30K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 1,013 | $27K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 6,795 | $27K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 305 | $25K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 1,417 | $24K |
| 93793 | <1% | 8,502 | $24K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 285 | $24K |
| 99350 | Prolong home eval add 15m | <1% | 888 | $23K |
| 0004A | <1% | 596 | $23K | |
| 90837 | Psychotherapy session, about an hour | <1% | 203 | $22K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 303 | $21K |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | <1% | 276 | $21K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 781 | $20K |
| 95886 | <1% | 440 | $19K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 770 | $19K |
| 96401 | <1% | 653 | $18K | |
| 93295 | <1% | 1,118 | $16K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 210 | $15K |
| 0071A | <1% | 332 | $15K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 225 | $14K |
| 20552 | <1% | 476 | $14K | |
| 76775 | <1% | 750 | $14K | |
| 20611 | <1% | 315 | $13K | |
| 51798 | <1% | 2,842 | $13K | |
| 0072A | <1% | 266 | $12K | |
| 20610 | <1% | 486 | $12K | |
| 94060 | <1% | 1,692 | $11K | |
| 93294 | <1% | 1,135 | $8K | |
| 94726 | <1% | 1,331 | $7K | |
| 0124A | <1% | 236 | $6K | |
| 93297 | <1% | 848 | $6K | |
| 73564 | <1% | 349 | $6K | |
| 93298 | <1% | 519 | $6K | |
| 99217 | <1% | 146 | $6K | |
| 94729 | <1% | 1,356 | $5K | |
| 17000 | <1% | 264 | $5K | |
| 73030 | <1% | 488 | $5K | |
| 77080 | <1% | 1,235 | $5K | |
| 81003 | <1% | 4,941 | $4K | |
| 99464 | <1% | 78 | $4K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 140 | $4K |
| 73110 | <1% | 226 | $4K | |
| 0054A | <1% | 121 | $4K | |
| 99292 | <1% | 79 | $4K | |
| 99306 | Prolong nursin fac eval 15m | <1% | 307 | $4K |
| 99219 | <1% | 60 | $4K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 540 | $4K |
| 93272 | <1% | 292 | $4K | |
| 99385 | <1% | 31 | $3K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 28 | $3K |
| 93227 | <1% | 218 | $3K | |
| 64493 | <1% | 55 | $3K | |
| 93016 | <1% | 313 | $3K | |
| 83013 | <1% | 69 | $3K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 225 | $3K |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 105 | $3K |
| 76857 | <1% | 223 | $3K | |
| S3005 | Performance measurement, evaluation of patient self assessment, depression | <1% | 271 | $3K |
| 99443 | <1% | 459 | $3K | |
| 59025 | Fetal non-stress test | <1% | 82 | $2K |
| 0031A | <1% | 125 | $2K | |
| 99224 | <1% | 86 | $2K | |
| 93018 | <1% | 312 | $2K | |
| 64494 | <1% | 56 | $2K | |
| 99234 | <1% | 44 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 316 | $2K |
| 87634 | <1% | 39 | $2K | |
| 99253 | <1% | 12 | $2K | |
| 99442 | <1% | 314 | $2K | |
| 85610 | <1% | 1,434 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 166 | $2K |
| 93280 | <1% | 137 | $1K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 27 | $1K |
| 17110 | <1% | 27 | $1K | |
| 95251 | <1% | 128 | $1K | |
| 95819 | <1% | 30 | $1K | |
| 97803 | <1% | 66 | $1K | |
| 93042 | <1% | 723 | $1K | |
| 99221 | <1% | 44 | $1K | |
| 36416 | <1% | 1,476 | $917.73 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 465 | $904.39 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 175 | $873.01 |
| 93015 | <1% | 27 | $848.42 | |
| 95811 | <1% | 13 | $838.60 | |
| 0064A | <1% | 30 | $779.80 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 33 | $698.89 |
| 17003 | <1% | 96 | $692.90 | |
| 90662 | <1% | 143 | $618.57 | |
| 99441 | <1% | 84 | $612.99 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 54 | $544.31 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 177 | $474.22 |
| 73562 | <1% | 31 | $456.26 | |
| 94010 | <1% | 32 | $444.83 | |
| 73140 | <1% | 28 | $436.01 | |
| 90656 | <1% | 24 | $434.94 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 30 | $375.09 |
| 88112 | <1% | 28 | $245.19 | |
| 73610 | <1% | 15 | $238.38 | |
| 73502 | <1% | 14 | $228.22 | |
| 99307 | <1% | 77 | $212.66 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 14 | $204.12 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 62 | $195.47 |
| 81025 | <1% | 27 | $173.80 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 12 | $158.00 |
| G0008 | Administration of influenza virus vaccine | <1% | 599 | $140.79 |
| 90791 | Psychiatric diagnostic evaluation | <1% | 16 | $123.33 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 73 | $121.75 |
| 80305 | <1% | 14 | $107.04 | |
| 99349 | <1% | 31 | $84.07 | |
| 93290 | <1% | 13 | $74.53 | |
| 83014 | <1% | 13 | $55.44 | |
| J9250 | Methotrexate sodium, 5 mg | <1% | 72 | $38.61 |
| 82962 | <1% | 305 | $31.82 | |
| 99152 | <1% | 115 | $30.00 | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | <1% | 43 | $17.40 |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 14 | $15.36 |
| 81002 | <1% | 12 | $13.20 | |
| 91300 | <1% | 4,539 | $0.02 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 46 | $0.00 |
| 91305 | 0% | 114 | $0.00 | |
| 91307 | 0% | 584 | $0.00 | |
| 91303 | 0% | 29 | $0.00 | |
| 91306 | 0% | 12 | $0.00 | |
| 99000 | 0% | 19 | $0.00 | |
| 91312 | 0% | 234 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Mass General Brigham Medical Group Western Massachusetts INC | Northampton, MA | $7.99M |
| Merrimack Valley Endoscopy, LLC | Haverhill, MA | $2.61M |
| Mass General Brigham Medical Group Suburban Massachusetts INC | Newton, MA | $892K |
| Mass General Brigham Medical Group Western Massachusetts INC | Northampton, MA | $20K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.